期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021; 20 (2)
Sepsis-associated encephalopathy causes long-term health problems in patients with sepsis. This review explores the pathogenesis of sepsis-associated ......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (1)
Background: Brain-Derived Neurotrophic Factor (BDNF) plays critical roles during development of the central and peripheral nervous systems, as well as......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (1)
Background & Objective: The pharmacokinetics and acute toxicity of a histone deacetylase inhibitor, Scriptaid, was unknown in the mouse. The aim o......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (3)
Primary Central Nervous System Lymphoma (PCNSL) is a rare invasive extranodal non-Hodgkin lymphoma, a vast majority of which is Diffuse Large B-Cell L......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (4)
Background: Due to the recent development of non-invasive examinations, more asymptomatic patients with Moyamoya Disease (MMD) have been diagnosed tha......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (4)
Background: Studies have found that autophagy could promote the clearance of A beta. To promote and maintain the occurrence of autophagy in Alzheimer'......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (4)
Stroke is a complex disease caused by genetic and environmental factors, and its etiological mechanism has not been fully clarified yet, which brings ......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (6)
Alzheimer Disease (AD) is the most prevalent type of dementia. Pathological changes in the All brain include Amyloid beta-protein (A beta) plaques and......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (7)
Recent studies implicate microbiota-brain communication as an essential factor for physiology and pathophysiology in brain function and neurodevelopme......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020; 19 (10)
Background: Mammalian target of rapamycin (mTOR) has been evidenced as a multi-modal therapy in the pathophysiological process of Acute Ischemic Strok......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019; 18 (1)
Objective: Botulinum toxin has many applications in the treatment of central diseases, as biological macromolecules, it is difficult to pass through t......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019; 18 (2)
Background: Xuesaitong mainly comprises Panax notoginseng saponins and has shown a promising feature in an acute ischemic stroke model; however, its e......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019; 18 (2)
Background & Objective: Alzheimer's disease (AD) and Parkinson's disease (PD) affect an increasing number of the elderly population worldwide. The......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019; 18 (3)
Background & Objective: NSCs therapy is considered one of the most potential methods for spinal cord injury (SCI). Methods: We build the SCI model......
期刊： CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019; 18 (3)
Background & Objective: Intracerebral hemorrhage (ICH) is the most devastating subtype of stroke, for which there are few effective interventions.......
